Cargando…
Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
Recent genome-wide analysis has demonstrated that somatic mutations in ARID1A (BAF250) are the most common molecular genetic changes in ovarian clear cell carcinoma (OCCC). ARID1A mutations, which occur in approximately half of OCCC cases, lead to deletion of the encoded protein and inactivation of...
Autores principales: | Maeda, Daichi, Mao, Tsui-Lien, Fukayama, Masashi, Nakagawa, Shunsuke, Yano, Tetsu, Taketani, Yuji, Shih, Ie-Ming |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100854/ https://www.ncbi.nlm.nih.gov/pubmed/21614196 http://dx.doi.org/10.3390/ijms11125120 |
Ejemplares similares
-
The roles of ARID1A in gynecologic cancer
por: Mao, Tsui-Lien, et al.
Publicado: (2013) -
Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas
por: Uehara, Yuriko, et al.
Publicado: (2015) -
Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas
por: Uehara, Yuriko, et al.
Publicado: (2015) -
Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
por: Yano, Mitsutake, et al.
Publicado: (2019) -
Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors
por: Ayhan, Ayse, et al.
Publicado: (2015)